Publication | Subvisible particle characterization: Why simply counting shadows leaves you in the dark

Summary

Significant advances in analytical technology over the past few years have improved the quantification and characterization capabilities for subvisible ( 1 - 100 μm) and submicron particles (≤1 μm).As the technology continues to improve so do the expectations of regulatory agencies for sponsors to characterize particles in these size ranges. However, multiple orthogonal methods are required to span the entire range and accurately characterize the particle profile. Each instrument has its own limitations based on detection method and properties of therapeutic protein products that must be well understood to generate high quality data. KBI Biopharma has extensive experience with particle detection methods, as well as, in-depth particle data analysis. KBI’s Particle Characterization Core team can help choose appropriate orthogonal particle to combine in order to accurately quantify, characterize and identify particles in specific therapeutic protein products for all size ranges based on clients’ needs.